|
⚲
|
| Keyboard |
| Martin Lewis | |
|---|---|
| Firm | |
| Address | 2308 W Fifth Street Plainview, TX 79072 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Jabez Biosciences Inc | 021-577807 | Director | 0.0 M | ||
| NOK Therapeutics Inc | 021-577751 | Director | 0.0 M of 0.0 M |
||
| NOK Therapeutics Inc | 021-562018 | Director | 0.6 M of 0.8 M |
||
| NOK Therapeutics Inc | 021-562020 | Director | 0.3 M | ||
| Jabez Biosciences Inc | 021-561483 | Director | 1.3 M of 3.0 M |
||
| Jabez Biosciences Inc | 021-561539 | Director | 0.3 M | ||
| Benchmark Operating Company LLC | 021-150498 | Executive Officer | 1.0 M of 1.0 M |
||
| IEG Permian Basin LLC | 021-149644 | Executive Officer | of 1.6 M |
||
| Benchmark Operating Company LLC | 021-146580 | Executive Officer | of 0.4 M |
||
| Episode LP | 021-84121 | Director | 107.4 M | ||
| Episode Inc | 021-84122 | Director | 2,847.3 M | ||